Live Nation Shares Approach High as California Ticket-Resale Limit Delayed
14 August 2026

Live Nation Shares Approach High as California Ticket-Resale Limit Delayed

NEW YORK, August 14, 2026, 11:25 EDT – Live Nation shares traded close to record levels after efforts to impose a ticket-resale cap in California were put on hold.

  • California’s proposal for a 10% ticket-resale limit was halted in a Senate fiscal committee on August 13.
  • A scaled-back anti-speculation measure moved forward to a full Senate vote with unanimous support.
  • Ticketmaster accounted for 40.5% of Live Nation’s adjusted operating income in the second quarter.

California legislators delivered a mixed outcome for Live Nation Entertainment on Thursday. The Senate Appropriations Committee decided not to advance a proposed 10% cap on resale prices, keeping it under consideration. Meanwhile, a different measure aimed at tickets sold before sellers have them cleared its latest hurdle.

Stock chart for NYSE:LYV

The result of the split is more favorable for Live Nation than widely discussed online. The halted proposal was the more significant risk to resale prices. Nevertheless, the bill that is moving forward may still increase compliance expenses throughout Ticketmaster’s platform.

The difference is significant as Ticketmaster generates substantial profit. Ticketing made up only 11.1% of total group revenue last quarter. However, it accounted for 40.5% of combined adjusted operating income, according to company data.

California measureMain provisionAugust 13 actionNear-term investor read
AB 1720Limits qualifying resale and marketplace fees to no more than 10% above the initial priceKept under submissionBroad risk of price caps diminishes
AB 1349Prohibits speculative listings and enhances anti-circumvention safeguardsMoved forward with a 7-0 vote; set for third readingSome compliance-related risk remains

The most recent version of AB 1720 is more limited than initially proposed. The legislation sets a cap for events held at independent venues, demands original ticket price disclosure, and limits fees on resale marketplaces. The bill officially remains active but is currently stalled in committee.

AB 1349 is now in the Senate’s floor process. The bill prohibits sellers from listing tickets they do not own or are not authorized to sell. Platforms are required to implement reasonable measures to block such listings. The measure also addresses bots, deceptive affiliation, and false scarcity promotions.

Q2 2026 segmentRevenueAdjusted operating incomeAOI margin
Concerts$6.44 billion$309.6 million4.8%
Ticketing$852.2 million$331.0 million38.8%
Sponsorship and advertising$383.0 million$256.9 million67.1%
Consolidated$7.67 billion$817.0 million10.7%

Ticketmaster’s large scale provides some protection. The company sold 90 million tickets with fees in the quarter, rising 8%. Secondary volume in North America remained unchanged. Executives stated that this segment made up a low-double-digit percentage of gross transaction value.

Live Nation backs the two California bills. Opponents claim the proposals may strengthen the main seller and undermine independent resale platforms. Assemblymember Matt Haney disagrees, highlighting Ticketmaster’s participation in the resale market.

Investors are already distinguishing between the solid demand for primary tickets and the uncertainties in the resale market. Live Nation finished Thursday at $186.06, gaining 0.4% after hitting a record high of $188.10. StubHub Holdings , however, dropped sharply as increased quarterly expenses wiped out most of its profit, even as revenue climbed 33%.

AnalystFirmRecommendationTargetUpside to $186.06
Steven CahallWells FargoBuy$22219.3%
Curry BakerGuggenheimBuy$21817.2%
Jason BazinetCitiBuy$21213.9%
Joseph StauffSusquehannaHold$1870.5%
Latest displayed recommendations through August 3, 2026. Source: Google Finance.

Analysts maintain an upbeat outlook, but the stock is trading close to the lowest target in coverage. According to Google Finance, out of 17 analysts, 16 recommend buying, one rates it a hold, and there are no sell ratings. The consensus price target stands at $207.82.

Operational momentum backs this view. Revenue for the second quarter increased 9% to $7.67 billion. Ticketing revenue was up 15%, and adjusted operating income gained 14%. Chief Executive Michael Rapino said “fans keep choosing to be in the room.”

The next step for AB 1349 is a Senate floor vote. California lawmakers face an August 31 deadline for bills to clear both chambers. Changes to the bill during this process could still alter how ticket marketplaces are affected.

Risks: AB 1720 may be brought back or proposed again. More extensive antitrust actions at the federal and state levels continue to pose significant valuation risks. Robust demand for tickets could also diminish if consumer spending declines.

Currently, the data suggest the issue is more limited in scope. California’s main effort at resale-price regulation has been halted. The remaining legislation targets behavior in the market, rather than focusing on the primary-ticket pricing model used by Ticketmaster.

TS2 TECH • EXTENDED COVERAGE

Further analysis

What was the impact of California's ticket legislation on Live Nation shares today?
Concerns over broad price caps declined after California's Senate Appropriations Committee placed AB 1720 on hold on August 13. The proposal aimed to limit eligible resale prices and marketplace charges to no more than 10% over the original amount. Meanwhile, a narrower bill targeting speculation, AB 1349, was approved unanimously to proceed to the Senate floor.
What role does Ticketmaster play in contributing to Live Nation's earnings?
Ticketing accounted for 40.5% of consolidated adjusted operating income in the second quarter, while representing just 11.1% of total revenue. Ticketing revenue climbed 15% to $852.2 million. Adjusted operating income was up 14% to $331.0 million.
Is AB 1349 still a potential risk to Live Nation?
Yes, but the scope is more limited. The proposed legislation aims to prohibit speculative ticket listings, obliges marketplaces to implement reasonable preventative measures, and addresses bots as well as deceptive sales claims. Businesses could face increased compliance expenses. Unlike AB 1720, the bill does not include a 10% cap on resale prices.
What are the key factors for investors to monitor going forward?
The upcoming catalyst is a California Senate floor vote on AB 1349. Each house faces an August 31 deadline to pass bills. Investors should monitor developments with AB 1720, should it be brought back, as well as observe if wider antitrust actions at either the state or federal level impact Ticketmaster's financial situation.
Iwona Majkowska

Iwona Majkowska is a financial markets journalist at TS2.tech, specializing in stocks, artificial intelligence and technology. A graduate of the Warsaw School of Economics, she previously worked in equity research and financial analysis before focusing on market reporting. Her daily coverage helps investors follow major developments across U.S. and global markets. Follow Iwona Majkowska on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 TACTICAL BUY

dLocal

NASDAQ: DLO 88 / 100
#5 BUY THE RESET

Tapestry

NYSE: TPR 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Moderna Secures U.S. mRNA Flu Vaccine Approval, Revenue Gains Not Expected Before 2027
Previous Story

Moderna Secures U.S. mRNA Flu Vaccine Approval, Revenue Gains Not Expected Before 2027